DNA

Ginkgo Bioworks Holdings, Inc.

1.38 USD
-0.09 (-6.12%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ginkgo Bioworks Holdings, Inc. stock is up 12.2% since 30 days ago. The next earnings date is Mar 4, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 February’s closed higher than January. In the last 9 Unusual Options Trades, there were 6 CALLs, 3 PUTs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Dec 16:33 16 Jan, 2026 2.00 CALL 280 1413
02 Jan 14:58 17 Jan, 2025 2.00 CALL 1678 16618
03 Jan 18:01 17 Jan, 2025 1.00 PUT 1918 3470
10 Jan 14:45 17 Jan, 2025 1.50 CALL 499 6773
05 Feb 16:34 15 Mar, 2024 1.50 PUT 4000 2304
06 Feb 16:22 16 Jan, 2026 0.50 CALL 700 586
06 Feb 16:49 16 Jan, 2026 0.50 CALL 1000 586
16 Feb 20:54 15 Mar, 2024 2.00 PUT 500 1156
20 Feb 19:01 16 Jan, 2026 2.00 CALL 501 3898

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.

  • Goldman Sachs
    Tue Jan 23, 09:00
    sell
    confirm
  • Goldman Sachs
    Mon Jan 22, 07:42
    sell
    confirm